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Objective: This study aimed to develop and in vitro characterize an organogel (OG) loaded Ibuprofen.  
ABSTRACT 
Methods: Organogel (OG) composed of water, isooctane, sorbitan esters, sorbitan monopalmitate (Span-40), and poly(oxyethylene) sorbitan 
monostearate (Polysorbate-60) was loaded with Ibuprofen. The partial phase behavior of ibuprofen OG was studied to optimize the formulation 
composition. 1.0% w/w Ibuprofen loaded OG were characterize for rheological, in vitro release and stability study.  
Results: Phase diagram showed an isotropic gel region at low water contents, which converted to emulsion on increasing water quantity. The 
rheological properties of the OG incorporating 1.0% w/w Ibuprofen shows the presence of two Tg’s and elastic behavior of gel, reflects the presence 
of an entangled network of aqueous tubules. The fractal dimension d f  value of 2.1 and 2.3 was obtained for the two curves (elastic and storage 
modulus), which is indicative of the formation of the densest gel structure. The diffusional release exponent (n) was found to be ~0.7 (0.5<n<1), 
which is indicative of non-Fickian, anomalous diffusion of the drug from the OG. The in vitro drug release exhibited release @ 7.04%/h 0.7/cm2
Conclusion: The study indicates the potential of OG for improved transdermal delivery of Ibuprofen. 
 from 
the OG. Ibuprofen containing OG was stable for 28 d in terms of chemical potency and gel stiffness at 4 °C and room temperature (~25 °C).  
Keywords: Microemulsion, Organogel, Phase-behavior, Gel-sol transition temperature, Fractal dimension, Ibuprofen, In vitro release, Pharmacokinetics 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) 
DOI: https://dx.doi.org/10.22159/ijap.2021v13i2.40108. Journal homepage: https://innovareacademics.in/journals/index.php/ijap  
 
INTRODUCTION 
Transdermal drug delivery is an attractive route for the systemic 
delivery of actives since its first commercialization in 1979 [1]. Topical 
delivery via the skin is a convenient, painless, and non-invasive 
approach that enables self-administration for patients [2, 3]. Many 
drugs have been delivered via the transdermal route and have become 
successful at clinical setup [4, 5]. It is well established that the outmost 
layer of the skin poses a major obstacle in permeating the drug across 
the skin layer. Subsequently, the drug employed should possess 
certain physicochemical properties of low molecular weight and 
sufficient hydrophilic-lipophilic balance to successfully penetrate the 
skin [6]. Non-steroidal anti-inflammatory (NSAIDs) drugs possess 
favorable physicochemical properties and have been explored for the 
transdermal route [1, 7]. Among NSAIDs, Ibuprofen is the most 
commonly used and most prominently prescribed drug to alleviate 
moderate pain, reduce swelling, control pyrexia, and treat arthritis at 
higher doses [8, 9]. However, like other NSAIDs, Ibuprofen carries a 
risk of gastric ulcers and sometimes bleeding when taken orally. 
Over the years, a variety of formulations have been explored to 
achieve transdermal delivery of a variety of therapeutic agents such 
as vesicle-based formulations, nanoparticles, microemulsions, and 
organogels and as so on [10]. Amongst them, organogels (OG) have 
attracted a great deal of attention due to their relevance in 
numerous applications such as transdermal drug delivery, 
separation science, templates, sensors, etc. They are 
thermoreversible bicontinuous systems consisting of oily surfactant 
solutions in which water is micro-emulsified, which on cooling 
develop a self-assembled interconnected network, mostly fibrillar or 
tubular, that stop macroscopic flow due to surface tension and 
capillary forces [11, 12]. The use of organogels has been proposed 
for the transdermal delivery of various drugs [13-16]. In this view, 
three major types of OGs comprising gelatine [17, 18], lecithin [19-
21] and sorbitan esters [22, 23] have been studied. The OG 
formulations of our interest are based on non-ionic sorbitan ester 
surfactants. These belong to a class of surfactants that form lamellar, 
toroidal, tubular aggregates, and star-shaped clusters in OGs, which 
were evaluated using optical microscopy, freeze-fracture electron 
microscopy, and X-ray diffraction techniques. The drug release 
characteristics from sorbitan ester OGs are also reported [24]. 
Previously, Upadhyay et al. have evaluated phase behavior, 
rheological, and drug release characteristics of sorbitan ester OG to 
optimize the physical properties of the final product because of the 
equipment like planetary mixers for semisolid processing impart high 
shear that affects gelation [23]. In this work, we aim to formulate and 
characterize sorbitan ester OG consisting of Ibuprofen. First, we report 
the phase diagram for the OG formation at different ratios of 
hydrophobic/hydrophilic sorbitan ester surfactants consisting of 
drugs. Then, we investigated rheological characteristics and fractal 
dimension. Nonetheless, research on topical bases for the 
improvement in drug permeation is continued and in this paper, we 
showed that OG is a better alternative for prolongs the effect of 
Ibuprofen from conventional ibuprofen preparations. 
MATERIALS AND METHODS 
Materials 
Span-40, Polysorbate-60, Isooctane and methanol were purchased 
from Sigma-Aldrich, India. Ibuprofen was a kind gift from IOL 
Chemicals and Pharmaceuticals Limited India. Distilled water was 
used in all experiments. 
Partial phase-behavior of Sorbitan Esters/Isooctane/Water 
System 
Phase studies were carried out as per published literature with 
some modification [23] by adding double distilled water to the 
mixtures of isooctane and surfactant [Span-40/Polysorbate-60 
(1:1)] in different weight ratios using a magnetic stirrer. After the 
addition of a water drop to the mixture, the mixture was examined 
visually for optical clarity and through cross polarizers for the 
presence/absence of the birefringent liquid crystalline phase. The 
addition of the water was stopped when the turbidity appeared. The 
concentrations of surfactant, isooctane, and water were then 
calculated. The appearance of turbidity was chosen as an endpoint at 
a particular ratio of surfactant/isooctane. The phase behavior of the 
systems was mapped on phase diagrams, with the top apex 
representing the isooctane and the other apices representing the 
surfactant (Span-40/Polysorbate-60 (1:1)) and water. The 
transparent, homogeneous, non-birefringent area enclosed within 
the endpoints was considered as water in oil (w/o) microemulsion. 
Based on the phase behavior study, OG compositions containing 1% 
(w/w) Ibuprofen were formulated and characterized. 
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Gel-sol transition temperature and fractional dimension 
The rheology experiments were performed as per published 
literature [23] using an AR500 stress-controlled rheometer (TA 
Instruments, U. K.). The dynamic rheology of organogel was studied 
by using steel parallel plate geometry of radius 20 mm and angle 0° 
with truncation gap 500 µm. The truncation gap was kept large to 
avoid breaking of the structures in the organogel sample. Frequency 
and strain sweep tests were carried out to specify the viscoelastic 
range. Sol-gel transition studies were conducted under the 
temperature ramp. The OG (0.16 g) was applied on the platform of 
the rheometer set up at a constant angular frequency (ω = 6.283 rad 
sec-1) and the temperature was varied from 15 °C to 35 °C. The 
storage modulus (elastic), G’, and the loss modulus (viscous), G”, 
were recorded and graphically plotted against temperature. The sol-
gel transition temperature was determined as the minima of the Tan 
δ (G’/G”) vs temperature curve. For the determination of the fractal 
dimension, the rheometer was set up at a fixed temperature (20 °C) 
and ω was varied from 0.5 to 50 rad sec-1. The relaxation exponent 
∆ was calculated by fitting the curve to the following power-law or a 
linear logarithmic equation [25]. 
G′(ω) =  α1ω∆ and G′′(ω) =  α2ω∆" ………………………. (1) 
logG′(ω) = logα1 + ∆′logω and logG"(ω)  =  logα1 + ∆" log ω ……. 
(2) 
where G(ω) is the modulus, ω is the angular frequency (rad sec-1), α is 
a constant and ∆ is the relaxation exponent. After the determination of 
relaxation exponent, a relationship of relaxation exponent with the 
fractal morphology of the gel network was established as published by 
Muthkumar [26] in the following equation:  
∆ = d(d + 2 − 2df)/2(d + 2 − df) ………………………. (3) 
Where d is dimension and df
df = (15 − 10∆)/(6 − 2∆)……………………. (4) 
 is the fractal dimension. For gel, d = 3, 
therefore the equation could be simplified as:  
Drug release through synthetic membrane  
The Ibuprofen containing OG was subjected to an in vitro drug 
release study through a cellophane membrane. The formulation 
(1.0g) was taken in a pretreated dialysis bag (as per the procedure 
suggested on the supplier, Sigma-Aldrich) clipped on both sides. The 
dialysis bag was immersed in 100 ml phosphate-buffered saline 
(PBS, pH 5.5) in the beaker maintained at 37±1 °C on a temperature-
controlled, magnetic stirrer plate. The contents of the beaker were 
stirred at 50 rpm using the magnetic bar. The sample from the 
beaker was withdrawn periodically for 24h and replaced 
immediately with an equal volume of PBS, pH 5.5. The samples were 
analyzed as explained later. The mass released (M) with time (t) was 
calculated according to the following power law [27]. 
Mt
M∞
= tn………………………… (5) 
where M∞
Stability 
 is mass released after an infinite time. 
The OGs containing the drug and respective placebos were stored for 
15, 30, and 45d at 4 °C and 25 ± 5 °C in collapsible aluminum tubes. 
The drug content was determined spectrophotometrically after 
dissolving the formulation in methanol against similarly treated 
placebos. Viscosities of OG formulations were also determined at 
weekly intervals using a Brookfield Digital Viscometer model LVDV-
I+(Brookfield Engineering Labs. Inc., USA). The formulations were 
also subjected to mechanical stress by centrifuging (Remi 
Centrifuge, India) at 10000 rpm for 20 min and the volume of phase 
separation of OG was noted. 
RESULTS AND DISCUSSION 
Phase behavior of OGs 
Phase behavior of OGs system consisting of isooctane, water, and 
surfactant mixture (Span-40 and Polysorbate-60) was investigated 
by plotting the pseudo-ternary phase diagrams in which each corner 
of the diagram represents 100% of that particular component. Fig. 1 
shows the phase diagram of the isooctane, water, and surfactant 
mixture. From the phase diagrams, it is clear that the area of OGs 
region decreased with the addition of the drug (grey). This 
correlates well with a previous study [23]. 
 
 
Fig. 1: Triangular phase diagram of OG formulations containing 
surfactant (Span40/Polysorbate-60, 1:1), isooctane and water. 
The encapsulated gray area in dark area (without Ibuprofen) 
shows the phase behavior of ibuprofen containing OG 
 
Rheological characteristics of OGs  
Gel-sol transition temperature (Tg) of OG formulations was 
determined using a Rheometer set up at a constant angular 
frequency ω = 6.283 rad sec-1
The viscoelastic nature of gels is a function of the microstructure 
network, which can be evaluated using the rheometer set up at fixed 
temperature (20 °C) and  varying ω from 0.5 to 100 rad sec
 and the temperature, Τ, were varied 
from 15 °C to 35 °C. A representative loss of storage modulus (G’) 
and loss modulus (G”) versus temperature curve obtained during 
the gelation process was plotted as shown in fig. 2. The curves 
present three domains: high and nearly constant values of G” 
corresponding to sol state, a sharp increase corresponding to gel 
microstructure formation and the last domain with a tendency to a 
plateau that could be linked to gel formation. Both the G’ and G” 
values were slightly increased with an increase in drug 
concentration at a particular temperature. The Tan δ was calculated 
as G”/G’. The curve between Tan δ and Τ was plotted and the Tg was 
obtained from the minima of the curve (fig. 2, inset). The parameter 
δ is the phase angle or phase shift between the deformation and 
response that is measured. It is the point where the viscoelasticity of 
the gel changes abruptly. A careful observation into this curve shows 
the presence of a shoulder (indicated by an arrow), indicating that 
the presence of two Tg’s. Thus, gel-sol conversion can be explained 
by a change in the arrangement of the gel network in two stages due 
to the incorporation of the drug, which suggests that the type of drug 
encapsulated in organogel affects OG network.  
-1. The 
elastic and viscous modulus shows an asymptotic increase in values, 
with the elastic modulus component [G’(ω)] always having a higher 
value than the viscous modulus component [G”(ω)], suggesting the 
predominantly elastic nature of the sorbitan ester OG within the 
indicated frequency range. The elastic behavior, in this case, reflects 
the presence of an entangled network of aqueous tubules. Fractal 
morphology of OG could be determined from the fractal dimension 
(d f) through a theoretical model for polyelectrolyte gels [25]. The 
relaxation exponent, ∆, was calculated fitting the power law 
equation to the G’(ω), G”(ω) vs ω curves or by plotting logarithm 
[G’(ω), G”(ω)] vs logarithm [ω] curves and determining the slope 
from the linear fit equation (fig. 3). The d f  value of 2.1 and 2.3 was 
obtained for the two curves (elastic and storage modulus), which is 
indicative of the formation of the densest gel structure. The values 
corroborate with reported studies [23]. 
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Fig. 2: The temperature-dependent loss of elastic modulus, G’ 
(solid legends), and viscous modulus, G” (open legends), of OG 




Fig. 3: A representative frequency (ω) dependence of G’(ω) 
(circles) and G”(ω) (triangles) curves of ibuprofen containing OG 
formulation in logarithmic mode. Relaxation exponents obtained 
from the slopes of the log G’(ω) and log G”(ω)vs Log ω curves 
Drug release from OGs 
The kinetics of ibuprofen release from OG was established by 
plotting a graph between percent cumulative drug release against 
time and the value of the diffusional release exponent (n) was 
calculated by fitting a power law to the curve (fig. 4). The value of n 
was found to be ~0.7 (0.5<n<1), which is indicative of non-Fickian, 
anomalous diffusion of the drug from the OG [27]. A graph of the 
percent cumulative amount of drug vs time 0.7 gives the release rate 
from its slope. The in vitro drug release exhibited release @ 7.04%/h 
0.7/cm2
 
 from the OG.  
 
Fig. 4: Cumulative percent drug released versus time curve. The 
drug release was studies in PBS buffer (pH 5.5) using a 
cellophane membrane. Solid circles: OG formulation. Solid 
squares: drug solution 
 
Stability 
The results of stability studies on ibuprofen containing OG 
formulation are summarized in table 1. The assay of drugs was more 
than 98% in all the formulations at the end of 45 d at 4 °C and room 
temperature (~25 °C) indicating that the chemical stability of 
ibuprofen in OG formulations was good. The formulations became 
stiffer over a 45 d period which was shown by an increase in the 
viscosity of the OG formulations. The OG formulations were resistant 
to centrifugal stress. 
 
Table 1: Stability of ibuprofen OG formulation 
S. No. Formulation code Time 
15d 30d 45d 
1. Assay (%) 99.1±1.2 98.4±1.4 98.7±0.9 
2. Viscosity (cps) 1200 1600 2000 
3. Centrifugal Stress* nil nil nil 
n=3 (Mean of three determination), *Phase separation on the centrifugation at 1000 rpm for 20 min  
 
CONCLUSION 
Organogel was made using of sorbitan monopalmitate/ 
polysorbate, isooctane and water. The sol-gel transition with 
decreasing temperature shows an abrupt denser network 
formation indicated by the higher fractal dimension value. The 
drug permeation was slow and displayed anomalous release 
behavior. The storage stability of OG was good for 45 d. This 
study proves that sorbitan monopalmitate/polysorbate-based 
organogel can be a good drug delivery system for transdermal 
delivery.  
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